Product Information
CLINDAMYCIN (PEDI) 75 MG/5 ML is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1288 per ML under NDC 65862059602. Its NADAC has been published 152 times since Nov 8, 2023.
FDA first approved this application on Apr 30, 2013. Its Orange Book therapeutic-equivalence code is AA.
Strength
75 mg/5mL
Manufacturer
Aurobindo Pharma LimitedNDC
65862059602
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CLINDAMYCIN PALMITATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202409FDA Approved
4/30/2013
TE Code
AA
On Market Since
4/30/2013
Pharmacological Classes
Price Statistics
The NADAC for CLINDAMYCIN (PEDI) 75 MG/5 ML has been published 152 times since Nov 8, 2023, and over the history we have for it it has declined 30.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1288 per ML |
|---|---|
| All-time high | $0.1955 (Apr 10, 2024) |
| All-time low | $0.1274 (Jul 22, 2026) |
| 52-week high | $0.1693 |
| 52-week low | $0.1274 |
| Median price | $0.1649 |
| Average price | $0.1608 |
| Largest weekly change | +49.2% (Aug 21, 2024) |
| Weeks tracked | 152 |
| Tracking since | Nov 8, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clindamycin Palmitate Hydrochloride (Pediatric) market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Lincosamide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLINDAMYCIN (PEDI) 75 MG/5 ML?
The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN (PEDI) 75 MG/5 ML, manufactured by Aurobindo Pharma Limited, is $0.1288 per ML (NDC 65862059602), effective Sep 30, 2026.
How has the price of CLINDAMYCIN (PEDI) 75 MG/5 ML changed over time?
Over the history we have for it, the NADAC for CLINDAMYCIN (PEDI) 75 MG/5 ML has declined 30.1%. It has been tracked across 152 weekly CMS publications since Nov 8, 2023.
What are the highest and lowest recorded NADAC prices for CLINDAMYCIN (PEDI) 75 MG/5 ML?
Since Nov 8, 2023, the NADAC for CLINDAMYCIN (PEDI) 75 MG/5 ML has ranged from a low of $0.1274 (Jul 22, 2026) to a high of $0.1955 (Apr 10, 2024), with a median of $0.1649 per ML.
Are there cheaper alternatives to CLINDAMYCIN (PEDI) 75 MG/5 ML?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLINDAMYCIN (PEDI) 75 MG/5 ML in a comparable dosage form, but none are currently priced below it.
Who manufactures CLINDAMYCIN (PEDI) 75 MG/5 ML?
CLINDAMYCIN (PEDI) 75 MG/5 ML (NDC 65862059602) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.